InspireMD Inc.

Stage 4 · Declining · week 3

As of Oct 22, 2026, InspireMD is in Stage 4, the downtrend phase, now in week 3 (since Oct 8, 2026). It closed at $0.46, 79.9% below its 52-week high and below its 200-day average, which is falling.

$0.46

+2.66% today

$21.2M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is NSPR early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 18w

S4 14w

S4 46w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 13w → S3 10w → S4 2w → S1 6w → S4 10w → S1 8w → S2 11w → S3 7w → S2 18w → S3 3w → S4 14w → S1 3w → S4 1w → S1 4w → S4 46w → S1 5w → S4 2w current

Total tracked: 165 weeks across 17 stage runs.

NSPR among Medical Devices110th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…110	NSPRInspireMD Inc.	Stage 4 · wk 3	11	−38.7%

vs 52W High

-79.9%

$0.44 lo$2.29 hi

79.9% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 3

1w13w26w

Week 3, early Stage 4 decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-58.5%

200 DMA: $1.11 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

4.43x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-38.7%

-32.4%

-64.1%

YTD

-75.3%

-80.4%

Scan Membership

Breakout Watch

Latest: 2024-12-09

4 appearances in last 60 days. First seen: 2021-02-04.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 3 · Vol 4.43x

2026-10-21S4

Wk 2 · Vol 8.50x

2026-10-20S4

Wk 2 · Vol 0.70x

2026-10-19S4

Wk 2 · Vol 1.23x

2026-10-16S4

Wk 2 · Vol 0.97x

2026-10-15S4

Wk 2 · Vol 0.61x

2026-10-14S4

Wk 1 · Vol 2.06x

2026-10-13S4

Wk 1 · Vol 1.01x

2026-10-12S4

Wk 1 · Vol 0.95x

2026-10-09S4

Wk 1 · Vol 3.64x

2026-10-08S41→4

Wk 1 · Vol 2.62x

2026-10-07S1

Wk 6 · Vol 1.73x

Moving averages & range

50 DMA

$0.72

200 DMA

$1.11

52W High

$2.29

52W Low

$0.44

5D Low

$0.44

Resistance levels (recent highs)

20d High

$0.70

60d High

$0.98

120d High

$1.25

250d High

$2.29

Next resistance

+52.2%

to 20d High

ROE

-202.8%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 0.7

InspireMD: quick answers

What stage is InspireMD in?

As of Oct 22, 2026, InspireMD (NSPR) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 8, 2026 and is in week 3. What the four stages mean

Is InspireMD in an uptrend?

No. InspireMD is in a Stage 4 downtrend. It trades 58.5% below its 200-day average, which is falling.

How far is InspireMD from its 52-week high?

InspireMD closed at $0.46 on Oct 22, 2026, 79.9% below its 52-week high of $2.29. Its 52-week low is $0.44.

How has InspireMD performed over the past year?

As of Oct 22, 2026, InspireMD is down 80.4% over the past year and down 75.3% so far in 2026.

Which sector and industry is InspireMD in?

InspireMD is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.